Archive · 28 Jan 2026
Trump Admin Selects 15 Drugs for Price Negotiations
The Trump administration has chosen 15 new drugs to negotiate lower prices for.
These drugs treat serious conditions like cancer, diabetes, and HIV.
The new prices will start in 2028.
This is part of a plan to make medicines more affordable for people with Medicare.
The drugs were picked because they are very expensive and used by many people.
The goal is to save money for seniors and taxpayers.
15 drugs, including treatments for cancer, diabetes, and HIV, selected for price negotiations.
New prices will take effect on 1 January 2028.
Negotiations for these drugs will occur in 2026.
Selected drugs accounted for $27 billion in Medicare expenditures and were used by 1,777,000 enrollees.
This is the third phase of the Medicare Drug Price Negotiation Program.
- Who
- The Trump administration and CMS
- What
- Selected 15 drugs for price negotiations
- When
- Announced on Tuesday, effective from 1 January 2028
- Where
- United States
- Why
- To reduce prescription drug costs for Americans
- Drugs Selected
- 15
- Conditions Treated
- Cancer, diabetes, HIV, arthritis, COPD, migraines, and more
- Negotiation Timeline
- 2026
- Effective Date
- 1 January 2028
- Total Medicare Expenditures
- $27 billion
- Medicare Enrollees Affected
- 1,777,000
- Announced By
- CMS Administrator Dr. Mehmet Oz
- Program
- Medicare Drug Price Negotiation Program